Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: Long-term follow-up of the STI571 0102 and 0109 trials

Richard T. Silver, Jorge Cortes, Roger Waltzman, Manisha Mone, Hagop Kantarjian

Research output: Contribution to journalLetter

29 Scopus citations
Original languageEnglish (US)
Pages (from-to)743-744
Number of pages2
JournalHaematologica
Volume94
Issue number5
DOIs
StatePublished - May 2009

Keywords

  • CML-AP
  • CML-BC
  • Chronic myeloid leukemia
  • Imatinib

ASJC Scopus subject areas

  • Hematology

Cite this